IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

被引:12
作者
Brugnano, R. [1 ]
Del Sordo, R. [2 ]
Covarelli, C. [2 ]
Gnappi, E. [3 ]
Pasquali, S. [3 ]
机构
[1] Osped S Maria Misericordia, Dept Nephrol & Dialysis, Piazza Menghini 1, I-06156 Perugia, Italy
[2] Univ Perugia, Sch Med, Dept Expt Med, Sect Pathol Anat & Histol, Perugia, Italy
[3] Santa Maria Nuova Hosp, UOC Nephrol & Dialysis, Reggio Emilia, Italy
关键词
IgM nephropathy; Minimal change disease; Focal segmental glomerulosclerosis; Nephrotic syndrome; Controversy; MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS; IMMUNOGLOBULIN-M NEPHROPATHY; IDIOPATHIC NEPHROTIC SYNDROME; GLOMERULAR-DISEASE; LONG-TERM; NATURAL-HISTORY; SINGLE-CENTER; FOLLOW-UP; DEPOSITS; CHILDREN;
D O I
10.1007/s40620-016-0269-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Immunoglobulin (Ig)M nephropathy (IgMN), known since 1978, is a very controversial clinicopathological entity characterized by IgM diffuse deposits in the mesangium at immunofluorescence whereas light microscop identifies minimal glomerular lesion, hypercellularity and expansion of the mesangium or sclerotic focal, segmental lesion. Clinically, it is a nephrotic syndrome, especially in pediatric patients, or asymptomatic proteinuria and/or isolated hematuria. These characteristics narrowly define IgMN between minimal change disease and focal segmental glomerulosclerosis, so it is not often recognized as a separate pathology. Homogeneous epidemiologic, pathogenetic, clinical or histological data are not available. Recent research on the pathogenetic role of mesangial IgM has, however, renewed interest in IgMN and naturally the controversies.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 50 条
  • [41] A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany
    Voelker, Linus A.
    Ehren, Rasmus
    Grundmann, Franziska
    Benzing, Thomas
    Weber, Lutz T.
    Brinkkoetter, Paul T.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 1983 - 1986
  • [42] Up to date of pathophysiology mechanism of idiopathic nephrotic syndromes: Minimal change disease and focal and segmental glomerulosclerosis
    De La Roque, Charlotte Dumas
    Combe, Christian
    Rigothier, Claire
    NEPHROLOGIE & THERAPEUTIQUE, 2018, 14 (07): : 501 - 506
  • [43] Transition from minimal change disease to focal segmental glomerulosclerosis related to occupational exposure: A case report
    Tang, Long
    Cai, Zhen
    Wang, Su-Xia
    Zhao, Wen-Jing
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (17) : 5861 - 5868
  • [44] CD80 and suPAR: Diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
    Davin, Jean-Claude
    PEDIATRIC NEPHROLOGY, 2014, 29 (08) : 1465 - 1466
  • [45] New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
    Qinjie Weng
    Qiongxiu Zhou
    Jun Tong
    Yuanmeng Jin
    Yunzi Liu
    Xialian Yu
    Xiaoxia Pan
    Hong Ren
    Weiming Wang
    Jingyuan Xie
    Nan Chen
    Clinical Proteomics, 2020, 17
  • [46] CD80 and suPAR: Diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
    Jean-Claude Davin
    Pediatric Nephrology, 2014, 29 : 1465 - 1466
  • [47] THE EFFICACY OF CYCLOSPORINE-A IN ADULT NEPHROTIC SYNDROME WITH MINIMAL CHANGE DISEASE AND FOCAL-SEGMENTAL GLOMERULOSCLEROSIS - A MULTICENTER STUDY IN KOREA
    LEE, HY
    KIM, HS
    KANG, CM
    KIM, SG
    KIM, MJ
    CLINICAL NEPHROLOGY, 1995, 43 (06) : 375 - 381
  • [48] Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis
    Zee, Jarcy
    Liu, Qian
    Smith, Abigail R.
    Hodgin, Jeffrey B.
    Rosenberg, Avi
    Gillespie, Brenda W.
    Holzman, Lawrence B.
    Barisoni, Laura
    Mariani, Laura H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (07): : 1411 - 1426
  • [49] Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
    Lee, Vincent W. S.
    Harris, David C. H.
    NEPHROLOGY, 2011, 16 (01) : 30 - 38
  • [50] Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis
    Wagrowska-Danilewicz, M.
    Danilewicz, M.
    NEFROLOGIA, 2007, 27 (06): : 710 - 715